Search results
Author(s):
Harold Bays
Added:
1 year ago
ACC.23/WCC — Dr Harold Bays, Science Officer for the Obesity Medicine Association, member of the Board of Trustees of the Obesity Medicine Association, and member of the Board of Directors of the American Society of Preventive Cardiology joins us to talk about obesity management and the emergence of anti-obesity drugs and multidisciplinary team approach.
Discussion Points:
Unmet Needs in the…
View more
Obesity and Weight Loss
Author(s):
C Richard Conti
Added:
3 years ago
Article
Start date:
May 12, 2024
End date:
May 15, 2024
ECO2024, the 31st European Congress on Obesity, has chosen the enchanting city of Venice, Italy, as its backdrop from the 12th to the 15th of May 2024.
This program is designed to be engaging, fostering interaction and discussions on the most pressing topics in the field. Innovative digital solutions will be employed to make scientific content accessible and to facilitate networking.
Eminent…
View more
Author(s):
Koji Hasegawa
,
Maki Komiyama
,
Yuko Takahashi
Added:
3 years ago
Smoking is a strong risk factor for the development of arteriosclerotic cardiovascular disease (CVD). Quitting smoking is a cornerstone of improved cardiovascular health, reducing the risk of developing CVD and the risk of overall mortality.1 It is astonishing that 7–28% of patients with coronary heart disease still smoke, but around half of smokers are planning to quit.2,3 Because the habit is…
View more
Author(s):
Laura Meems
Added:
10 months ago
ECO 23 - We are joined by Dr Laura Meems (University Medical Center Groningen, NL) to discuss the impacts of obesity on the outcomes of heart failure.In this interview, Dr Meems outlines the effects of obesity on the progression and management of heart failure and the available treatment options for patients in 2023.Interview Questions:How does obesity impact the progression and management of…
View more
Author(s):
Rajarshi Banerjee
,
Paul Leeson
Added:
3 years ago
There is a great concern among both health professionals and the public about the best way of managing the current explosion in adult and adolescent obesity. In the US, the prevalence of obese teenagers between 1980 and 2007 increased from 5 to 18 %1 and the UK has seen a similar trend, especially in boys (see Figure 1). Since a substantial proportion of obese teenagers become obese adults,2,3 it…
View more
Author(s):
Morihiro Matsuda
Added:
3 years ago
Background and aims: Obesity-induced chronic low-grade inflammation is causally associated with insulin resistance leading to dyslipidaemia, which is a residual risk for coronary artery disease in patients on statin therapy. The aim of this study is to clarify the impacts of adipocytokines and obesity-associated inflammatory markers on apolipoprotein (apo) A1 and B in patients on statin therapy.
…
View more
Author(s):
R Sane
Added:
3 years ago
Aim: Chronic heart failure (CHF) is a common cause of mortality and morbidity. Obesity influences the CHF development and prognosis. This study was conducted to assess effect of heart failure reversal therapy (HFRT), a combination of panchakarma and allied therapies, on anthropometric parameters in CHF patients.
Methods: This retrospective study was conducted on data of patients who visited…
View more
Author(s):
Lee Kaplan
,
Fatima Cody Stanford
,
Filip Knop
,
et al
Added:
8 months ago
Radcliffe Medical Education bring together a distinguished panel of globally renowned experts who provide guidance on navigating the ever-changing landscape of obesity and metabolic health management.
Under the chairmanship of Prof Jason Halford(University of Leeds, UK), the panel includingDr Lee Kaplan(Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, US),Dr…
View more